NCT04003441

Pharmacokinetics and Safety of DWP14012 Tablet A and Tablet B in Healthy Volunteers

A Randomized, Open-label, Single Dose Study to Evaluate the Safety and Pharmacokinetics of DWP14012 Tablet A and DWP14012 Tablet B in Healthy Volunteers

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (estimated)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: All
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This is a randomized, open-label, single dose study to evaluate the safety and pharmacokinetics of DWP14012 tablet A and DWP14012 tablet B in healthy volunteers

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	DWP14012 tablet A	Period 1: DWP14012 tablet B Period 2: DWP14012 tablet A
DRUG	DWP14012 tablet B	Period 1: DWP14012 tablet A Period 2: DWP14012 tablet B

Timeline

• Start date: 2019-06-01
• Primary completion: 2019-08-01
• Completion: 2019-08-01
• First posted: 2019-07-01
• Last updated: 2019-07-01

Locations

1 site across 1 country: South Korea